Neuropsychological assessment in epilepsy by Baxendale, S
Neuropsychological Assessment in Epilepsy 
Sallie Baxendale 
 
1Department of Clinical and Experimental Epilepsy,  




Address for Correspondence:-  
 
Dr Sallie Baxendale 
ESRC Epilepsy Society 
Chesham Lane 




Tel: +44 1494 601353 
Fax: +44 207 813 2516 
Email: s.baxendale@ucl.ac.uk 
 
Competing Interests :  None 
Contributorship :  Single author paper 
Acknowledgements :  None 
 
  
Neuropsychological assessment in epilepsy 
 
Abstract 
The role of the neuropsychological assessment in the management of 
people with epilepsy has evolved considerably over the past 25 years. 
This paper describes some of the most common applications of a 
neuropsychological assessment in the diagnosis, management and 
treatment of people with epilepsy. It describes the factors that influence 
the interpretation of neuropsychological test scores in this patient group 
and outlines the limitations of the investigation. Guidelines for the 
optimal timing of a referral are given, together with timelines and 
indications for reassessment. A checklist is provided to help the 
referring clinician get the most from a neuropsychological assessment 




The role of the neuropsychological assessment in the management of 
people with epilepsy has evolved considerably over the past 25 years. 
Prior to the advent of MRI, patterns of cognitive strengths and 
weaknesses derived from a neuropsychological assessment were used to 
lateralise and localise cerebral pathology in this group. The advances in 
structural and functioning imaging over the past quarter of a century 
mean that this is no longer the primary role of a neuropsychological 
assessment in this population.[1]   
However far from hastening the demise of the neuropsychological 
assessment, new imaging techniques have enhanced the role of 
traditional tests in the clinical management of people with epilepsy.   
This paper describes the ways in which a neuropsychological 
assessment can help in the diagnosis, management and treatment of 
people with epilepsy and provides some recommendations for getting 
the most out the investigation for this patient population.  
 
What is a Neuropsychological Assessment? 
 
A neuropsychological assessment consists of the administration of a 
number of tests which have been standardised and normed on healthy 
populations. Every neuropsychological test has a ceiling and a floor. 
These are the limits of the best and worst performances possible on the 
task. For example on a ‘Count to 3’ task, the ceiling of the test would be 
the ability to count to 3. Since well over 99% of the adult population can 
do this, it would be a test with a very low ceiling. Full marks on the test 
would not distinguish the patient whose counting limit is 4 from one 
who can solve complex quadratic equations in lightning speed. Most 
tests are therefore standardised so that the top and bottom scores are 
only returned by 2% of the general population. Anyone completing 
these standardised tests will obtain a score which will provide a 
measure of how well they are functioning compared to an age matched 
sample of their healthy peers and/or patients with similar or other 
conditions. These scores tend to be normally distributed and are 
converted to either z scores or a percentile rank to allow comparison 
between tests. See Figure 1. 
 
Figure 1: The Normal Distribution and Psychometric Conversion Scores 
<<here>>> 
 
Not all neuropsychological test scores are normally distributed and 
some tests may be based on pass/fail criteria or have ‘cut off’ points for 
the identification of an abnormal pattern of response. 
Most neuropsychological assessments will generate a large number of 
measures of function in a number of cognitive domains including 
general intellectual ability, memory function, expressive and receptive 
language skills, executive function and perceptual abilities. This creates 
a cognitive profile of strengths and weaknesses across multiple domains.  
These cognitive profiles are examined to determine clinically significant 
deficits in relation to the individual’s estimated pre morbid level of 
function in each cognitive domain (where appropriate) and also in 
relation to the pattern and level function seen in their healthy, age 
matched peers.  
 
When can a neuropsychological assessment help in the management of people 
with epilepsy? 
 
Table 1 describes some of the most common applications of a 
neuropsychological assessment in the diagnosis, treatment and 
management of people with epilepsy.  
 
<<Table 1 here>> 
 
Interpreting the Results 
Just as it is increasingly recognised that epilepsy is a disorder of cerebral 
networks [2] so we have moved away from a phrenological approach of 
assigning specific cognitive functions to the role of specific cerebral 
structures.  
 
Figure 2. A neuropsychological assessment is not phenology! <<here>> 
 
Rather we now understand that difficulties on particular 
neuropsychological tasks represent dysfunction within the underlying 
network that sub serves that function. This disruption of function can be 
the result of a large number of factors. These are illustrated in Figure 3.  
 
Figure 3: Factors influencing performance on neuropsychological  
tests in epilepsy (© ILAE, reproduced with permission) [1] <<here>> 
 
 
The neuropsychological assessment is unique amongst the standard 
diagnostic assessments in epilepsy. The clinical significance of the 
cognitive profile can only be fully interpreted in the light of the 
outcomes of other investigations.  This is not the case with an MRI 
where a cavernoma will present as a cavernoma, regardless how a 
patient is feeling on the day of the scan or when they last had a seizure.  
However, in a neuropsychological assessment a poor score on a test can 
reflect a large number of both organic and non organic factors, some of 
which may be permanent (eg underlying structural pathology), others of 
which may be transient (post ictal disturbance, interictal sub clinical 
EEG discharges, depression etc) or reversible (e.g. medication effects) or 
even specific to the assessment itself (e.g. poor motivation and test 
anxiety).   
A skilled neuropsychologist will need to examine the evidence for each 
of the factors illustrated in Figure 3 and their interactions in order to 
interpret the test results for each patient. This means the more 
information the neuropsychologist has about the patient at the time of 
the assessment, the better their interpretation will be. In most settings 





Unlike a scan or an EEG, a neuropsychological assessment assesses the 
person and not the brain. There are a number of limitations associated 
with this kind of assessment and it will not yield useful results for 
everyone. The following limitations should be considered when 
considering referring someone with epilepsy for a neuropsychological 
assessment. 
 
1. Most of the tests we use are culturally specific and have been 
standardised using a British population who have English as their 
first language. This means that the norms are only valid for this 
population, i.e. people who have been educated within the UK and 
for whom English is their first language. Although there are some 
non-verbal tests which have been designed to be culturally 
neutral, any assessment using just these tasks will be limited. 
Whilst interpreters can be used to administer some tests, even 
qualified interpreters are not trained in the standardised 
administration of psychometric tests. It is possible to end up with a 
measure of the ‘joint IQ’ of both the patient and the translator in 
these situations! Even in faithful translation, the problems of the 
unrepresentative normative sample remain. Caution should 
therefore be applied in the interpretation of the findings from a 
neuropsychological assessment in people who differ in important 
respects from the normative sample of the test. 
 
2. Most neuropsychological tests are pencil and paper tasks or 
require the patients to answer questions put to them by the 
neuropsychologist (who then records their answers, with a pencil 
on paper). Computerised test batteries are gradually becoming 
more widespread in use, but technology has not transformed the 
neuropsychological assessment in the way that it has in other 
disciplines. This is because an integral part of a 
neuropsychological assessment is the observation of ‘how and 
why’ someone is failing on a task, not just whether or not they can 
do it, and this requires close observation and the engagement of 
the clinician with the patient throughout the assessment. Because 
most of our tests rely on someone being able to see, hear and 
manipulate a pencil, our range of investigations is limited if 
someone has significant sensory or motor impairments. This does 
not mean that a neuropsychological assessment cannot provide 
useful information in these cases, but it does mean that the 
assessment will have to be tailored to accommodate these 
impairments and that it may not be possible to get a reliable 
measure of function in all cognitive domains  
 
3. As stated earlier, every neuropsychological test has a ceiling and a 
floor. By definition, people who have been diagnosed with  
learning disability will have an IQ of 70 or less and will score at or 
below the second percentile on tests of intellectual function. 
Although not always the case, it is common for function in other 
cognitive domains to be similarly compromised in the learning 
disability population. This can result in a very flat 
neuropsychological profile, with every score on every task falling 
below the 2nd percentile. This does not mean that the individual 
does not have cognitive strengths and weaknesses but rather that 
the standardised tests are not sensitive to these patterns in this 
population, limiting the value of the assessment in some cases.   
 
4. By far the biggest factor that can limit the validity and reliability of 
neuropsychological test scores is the motivation is the patient. If a 
patient is not willing to do their best on the tests, we will not get 
valid data. A neuropsychological assessment can be a tough 
investigation. Unless they are in the top 2% of the population, 
every patient will be pushed until they can’t answer the questions. 
As they reach the limits of their cognitive capacity it requires 
increasing effort not just to give up. Patients who are anxious and 
depressed or who just don’t see the point of the investigation will 




If a patient has undergone a full neuropsychological assessment, most 
neuropsychologists will advise waiting at least nine months before any 
reassessment is attempted. This is because practice effects can have a 
significant impact on performance the second (or third or fourth…) time 
around. These practice effects can mask underlying deterioration if a 
reassessment is carried out too soon. Exceptions to this rule are specialist 
serial assessments that are conducted as part of a treatment evaluation 
(for example surgical follow-up) where the standardised test batteries at 
each stage of treatment and follow-up have been carefully designed, 
employing parallel test batteries to minimise practice effects. Shorter 
test-retest intervals can also be used in circumstances where the initial 
assessment was clearly compromised by factors that have since resolved 
such as drug toxicity or psychological disturbance. 
Routine reassessment is not advised for most people with epilepsy since 
over exposure results in a reduction of the power of the tests to detect 
both impairment and change in function. If a patient has undergone an 
assessment that revealed significant memory impairment with function 
below the 2nd percentile, further assessment a year down the line when 
they continue to complain of memory problems is unlikely to help in 
their management since it is likely to show the same pattern. In the 
absence of any other features of progressive deterioration such a patient 
should be referred for memory rehabilitation rather than undergo serial 
assessments that are highly likely to yield the same results. Unless you 
think it is likely that something has changed, a reassessment is unlikely 
to help.  
 
The impact of Antiepileptic Drugs  
 
Given the volume of the literature on the effects of antiepileptic drugs 
(AEDs) on cognition, there are surprisingly few well controlled studies 
published. As a general rule of thumb, older AEDs are thought to have 
more impact on cognition than newer ones, and those on polytherapy 
are often more slowed up than those only taking one drug, but the 
impact is different for different people and there are some notable 
exceptions to these rules. Whilst most AEDs are associated with a degree 
of cognitive slowing, Topiramate appears to have a specific impact on 
verbal function and significant reductions in verbal fluency and 
intellectual function have been reported in some patients. A recent fMRI 
study reported medication-specific effects (TPM vs ZNS vs LEV) on the 
functional neuroanatomy of language and working memory networks, 
with TPM and ZNS associated with dysfunction in frontal and parietal 
cognitive networks and associated impaired performance on associated 
tasks [3]. The indirect impact of AEDs on cognition should also be 
considered. The mood disturbance reported by some people taking 
Levetiracetam can also lead to poor cognitive function for some. The 
cognitive profile of any AED should be carefully considered by the 
prescribing neurologist, particularly when they are considering changes 
that could have a dramatic impact on academic performance at key 
stages of an individual’s life.  
    
Getting the most from a Neuropsychological Assessment 
 
The following checklist will help you get the most out of a 
neuropsychological assessment. 
 
1. Think about the clinical question you want the neuropsychological 
assessment to address. 
 
Whether it’s establishing a cognitive baseline prior to medication 
changes, capacity to consent to treatment or advice about employment 
options, the more specific the questions you ask in your referral, the 
more tailored the subsequent assessment will be. As a rule of thumb, the 
more general the referral, the more general the report you will get back. 
Referrals do not have to be limited to just one question, often the same 
results can be used in a number of ways, but it is only by asking the 
questions, that the neuropsychologist will know what you want from 
the results.  
  
2. Give as much information in the referral as possible 
 
Remember that there many factors that contribute to a 
neuropsychological profile. If your neuropsychologist does not have 
ready access to the clinical history of the patient, include as much 
clinical information as possible in your referral. This information doesn’t 
need to be tailored specifically to the neuropsychologist, just include 
copies of the most recent clinic letters. Any screening data that you have 
administered in the clinic (HADS, QoLIE, ACE-R, MOCA) is useful but 
not essential, as most neuropsychological assessments will include 
measures in these domains.  
 
3. Prepare the patient 
 
Tell your patient why you want them to have the tests and how you 
think they will help. Give them some idea of what to expect. It is part of 
the job of a neuropsychologist to explain the nature of the tests and to 
establish a good rapport with the patient before they start testing them, 
but the neurologist can do a lot of the ground work to ensure a valid 
assessment by ensuring the patient is on-board, at least with the 
rationale behind the assessment, before they arrive. If a patient arrives 
with a good idea of why they have been referred and how the results of 
the tests will be used to help manage their condition, their motivation to 
complete the tests to the best of their ability will be better than if they 
have no idea why they have been referred. Bear in mind that if you 
typically have difficult clinical consultations with a patient, these 
difficulties will be magnified under the stressful conditions of a 
cognitive assessment and it may not be possible to get valid results.  
 
4. And finally… 
 
There are no magic bullets when it comes to cognitive dysfunction in 
epilepsy. Memory problems, difficulties with attention and 
concentration and executive dysfunction are often an integral part of the 
condition, because seizures and cognitive difficulties are both a 
manifestation of a common underlying brain pathology. To make things 
worse, the cognitive problems associated with the pathology are often 
exacerbated by the treatments aimed at reducing the seizures, be they 
antiepileptic medications or surgery. Clinicians often mistake this for 
common knowledge, but it is remarkable how many people with 
epilepsy report that these aspects of their condition have never been 
explained to them. When people with epilepsy complain of memory 
problems in the clinic, education about the wider manifestations of the 
condition should begin there and then, to ensure realistic expectations of 




1. Being clear about what you want from a neuropsychological 
assessment and how the results will affect your management of a 
patient before you refer will ensure that the results you get back 
are useful. 
2. Prepare the patient. Preparation for the assessment begins in the 
neurology consultation, when you decide to refer. The better 
prepared the patient, the more valid the results will be.  
3. Think carefully before you refer for a reassessment. A 
neuropsychological assessment should be used sparingly to 
maintain the sensitivity of the tests.   
4. There are no magic bullets when it comes to cognitive dysfunction 
in epilepsy. Ensure the patient has realistic expectations of any 
neuropsychological investigations you may order.  
 
  
Table 1. Common applications of a neuropsychological assessment in the 
diagnosis, treatment and management of people with epilepsy. 
Determine mental capacity Under the Mental Capacity Act (2005) mental capacity is 
not universal but situation specific. Data from a 
neuropsychological assessment can be used to determine 
whether some has the capacity to make decisions in a 
variety of situations from consent to receive/refuse 
treatment to the management of their affairs. 
Assess and monitor medication 
effects 
Some antiepileptic medications can have significant 
cognitive side effects. A neuropsychological assessment 
can be used to assess the cognitive cost/benefits of these  
medications, particularly for young people with respect to 
their education. 
Aid in the differential diagnosis of 
epilepsy/Non Epileptic Attack 
Disorder 
A very abnormal profile may indicate the presence of a 
functional disorder. 
Provide the basis for a cognitive 
rehabilitation program 
The results of a neuropsychological assessment can be 
used to create a tailor made rehabilitation program to 
reduce the impact of any cognitive deficits with an 
organic basis on everyday function.  
Provide the basis for counselling 
regarding 
employment/educational options 
People with epilepsy and heir carers can develop both 
under and over expectations regarding the likely impact 
of their condition on their life opportunities. A 
neuropsychological assessment can provide a sound basis 
to ensure someone is able to function at their full 
potential. 
Specialist applications in epilepsy 
surgery  
These include:-  
a. Lateralising/localising seizure focus in MR negative 
cases 
b. Preoperative prediction of postoperative cognitive 
changes 
c. Ensuring informed consent  
d. Implementation of prehabilitation for patients at high 
risk of a postoperative cognitive decline. Prehabilitation is 
cognitive rehabilitation implemented prior to the loss of a 
function. Epilepsy surgery patients are unique amongst 
neurological patients as we can predict both the nature 
and extent of the neuropsychological deficit they are likely 
to experience prior to the surgery that will cause it. We 
can utilise a patient’s intact memory functions before they 
deteriorate to instil the routines and strategies they will 
need after the surgery to reduce the impact of post-
operative cognitive decline. 
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